Hepion Pharmaceuticals Inc. (HEPA)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 28 Nov 2023 |
WIJNGAARD PETER |
Director |
27 Nov 2023 |
2,500 |
3.05 |
7,625 |
| 28 Nov 2023 |
WIJNGAARD PETER |
Director |
24 Nov 2023 |
2,500 |
3.09 |
7,725 |
| 20 Sep 2023 |
WIJNGAARD PETER |
Director |
19 Sep 2023 |
1,000 |
5.64 |
5,640 |
| 20 Sep 2023 |
WIJNGAARD PETER |
Director |
15 Sep 2023 |
861 |
5.37 |
4,624 |
| 20 Sep 2023 |
WIJNGAARD PETER |
Director |
15 Sep 2023 |
1,000 |
5.82 |
5,820 |
| 20 Sep 2023 |
WIJNGAARD PETER |
Director |
15 Sep 2023 |
139 |
5.45 |
758 |
| 19 Sep 2023 |
FOSTER ROBERT T |
CEO and Director |
18 Sep 2023 |
1,600 |
5.60 |
8,960 |
| 18 Sep 2023 |
FOSTER ROBERT T |
CEO,CSO and Director |
15 Sep 2023 |
1,600 |
5.40 |
8,640 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock